Cytokine regulation of immunopathology in toxoplasmosis.
about
Toxoplasma gondii-induced neuronal alterationsRoles of interleukin-17 in uveitisDecrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infectionThe role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice.IL-17-expressing CD4⁺ and CD8⁺ T lymphocytes in human toxoplasmosis.Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6.Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels.Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis.Toxoplasma gondii infection in humans in China.Lack of a Functioning P2X7 Receptor Leads to Increased Susceptibility to Toxoplasmic Ileitis.Th17 cells in human disease.Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondiiAltered endochondral ossification in collagen X mouse models leads to impaired immune responsesCholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.Spinal cord pathology in chronic experimental Toxoplasma gondii infection.Therapy for ocular toxoplasmosis--the future.Dectin-1-CD37 association regulates IL-6 expression during Toxoplasma gondii infection.Immunopathology in ocular toxoplasmosis: facts and clues.Associations between Polymorphisms within Interferon Gamma and Tumor Necrosis Factor Genes and Toxoplasma Retinochoroiditis in Ghanaian Patients.Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii.Experimental Toxoplasma gondii and Eimeria tenella co-infection in chickens.Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute ToxoplasmosisComparison of dynamic expressions of Tim-3 and PD-1 in the brains between toxoplasmic encephalitis-resistant BALB/c and -susceptible C57BL/6 mice.Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis.CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract.Upregulated expression of Tim-3 involved in the process of toxoplasmic encephalitis in mouse model.Toxoplasma gondii Manipulates Expression of Host Long Noncoding RNA during Intracellular InfectionImpact of Engineered Expression of Mitochondrial Association Factor 1b on Infection and the Host Response in a Mouse Model
P2860
Q27027025-53762B9C-DBAC-4D67-848C-1126E14A4C18Q28079126-95A6443B-F900-4BC1-A9FE-94264E30F5C7Q33624096-42C2766A-41B9-4D3B-8E62-2E87161149BFQ33631447-CEDD36D1-CCB8-4A40-BBA2-C04E84F7D39EQ34079369-55AC7BC9-6201-47F3-8689-21152DC4DF64Q34119325-D635E38A-B20B-49D7-9198-78C0E66E1C8CQ34121309-87001EF2-622D-4369-8065-4347C561ED3CQ34157182-E87AE419-8531-4FAC-8BC3-0FC0CD48601EQ34330571-4566137C-B829-402B-8BD7-996B85DAB806Q34613996-783269FC-0384-49B9-B749-E302FFDC3B65Q35215763-8E1B6030-1D7F-4226-9827-384A196D8379Q35656877-51A6B203-05F6-47FB-9DAD-CA031A8C597FQ35820734-C383FCC6-89FB-46DD-89DD-2F15F881BDE1Q36160414-44E6FEDA-8411-4AB8-9DAF-7675DB12F785Q37072206-EEAEF37F-962C-4F8B-A8FB-DBAEDF611496Q37273216-4401A67C-4F3A-4CA3-BD9A-20A705E4408AQ37577380-49F4A426-EB43-4031-B24C-169358C68222Q37640229-B6806166-4F8B-45A3-809F-4CA25B113D86Q38101597-27FD11B1-E822-48E1-A6DA-3EBECC6AB025Q38990827-DDA961F3-968C-41D4-B298-94561DFCB233Q39980904-0BE31634-B8D2-46E4-8304-EFC83FE84952Q40713175-C689E9AC-C0D0-4FF1-B1A5-E3F8237F94FBQ41872148-C8A10627-6D32-469A-95D1-7F5B4F6201FCQ41990571-D5A3C4C5-49C2-47C0-A72F-897640AAF55CQ42140038-7BA5961D-939B-42C1-915A-B27529BE1670Q42239888-DC387FFA-91C2-425C-A8E3-493DEFAAC156Q43202341-158F4959-6014-42BC-A509-EC27A34A72DAQ44498184-7C0C18D5-3DFC-4FEA-A6C1-113BCD2637D6Q46784433-82C4A21C-2D72-4CA8-9052-DF42919A436AQ47137314-582471A4-89AD-472D-858D-25CA08F8C212Q51063368-8F773BCB-918C-46B3-939E-72DA2A07D82EQ57292463-EB4DC160-5B4C-452D-85C4-3225CF9D45E1Q58547033-C9A6953F-1D89-4BFF-8273-C75D4C745ADE
P2860
Cytokine regulation of immunopathology in toxoplasmosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cytokine regulation of immunopathology in toxoplasmosis.
@ast
Cytokine regulation of immunopathology in toxoplasmosis.
@en
type
label
Cytokine regulation of immunopathology in toxoplasmosis.
@ast
Cytokine regulation of immunopathology in toxoplasmosis.
@en
prefLabel
Cytokine regulation of immunopathology in toxoplasmosis.
@ast
Cytokine regulation of immunopathology in toxoplasmosis.
@en
P2860
P356
P1476
Cytokine regulation of immunopathology in toxoplasmosis.
@en
P2093
George S Yap
Pamela J Gaddi
P2860
P304
P356
10.1038/SJ.ICB.7100038
P577
2007-01-16T00:00:00Z